Hematology
For information on the following Clinical Trials, please contact the
Hematology, Oncology and Stem Cell Transplantation Department
at 773-880-4562 during 8:30 AM to 5:00 PM Central Standard Time.
| |
Hemophilia |
Investigator |
| 1 |
Controlled Trial of Immune-Tolerance Induction (ITI) |
Geoffrey Allen, MD |
| 2 |
Factor XIII Fibrogammin P |
Geoffrey Allen, MD |
| 3 |
Genetics of Inhibitor in Siblings with Hmophilia |
Geoffrey Allen, MD |
| 4 |
Recombinant Human Factor IX (rFIX) for Treatment of Hemophilia B |
Geoffrey Allen, MD |
| 5 |
Universal Data Collection (UDC) |
Geoffrey Allen, MD |
| 6 |
Hemophilia and Thrombosis Research Society Registry (HTRS) |
Geoffrey Allen, MD |
| 7 |
Hemophilic Genotype, Inhibitors and Response to Immune Tolerance |
Geoffrey Allen, MD |
| 8 |
Previously Untreated Hemophilia Patients-ADVATE |
Alexis Thompson, MD |
| 9 |
Risk Factors for Inhibitor Development in Mild or Moderate Hemophilia A |
Geoffrey Allen, MD |
| 10 |
Haemocomplettan P |
Geoffrey Allen, MD |
| 11 |
Response to DDAVP in Children with Type 1 Von Willebrand Disease Using the PFA-100 |
Geoffrey Allen, MD |
| |
|
|
|
Sickle Cell
|
Investigator |
| 12 |
Novartis 2411 Registry Trial |
Alexis Thompson, MD |
| 13 |
Novartis 109E - Long-term Treatment with ICL |
Alexis Thompson, MD |
| 14 |
Novartis US19 - T2 Star |
Alexis Thompson, MD |
| 15 |
Pulmonary Hypertension Prevalence Study (PHT) |
Robert Liem, MD |
| 16 |
Pulmonary Hypertension-Hydroxyurea Pilot Trial (PHT-HU) |
Robert Liem, MD |
| 17 |
Quality of Life (QOL) |
Robert Liem, MD |
| 18 |
Silent Infarct Transfusion Trial in Sickle Cell Patients (SITT) |
Alexis Thompson, MD |
| 19 |
sPLA2 Inhibitor in Sickle Cell Patients |
Alexis Thompson, MD |
| 20 |
Sickle Cell Patients w Stroke and Transfusions Changing to Hydroxyurea (SWiTCH) |
Alexis Thompson, MD |
| 21 |
Genetic Basis of Variability of Opioid Resp. in Ped Adoles Patients w/SCD A. |
Kyle Mack, MD |
| 22 |
Tricuspid Regurgitant Jet Velocity in Children and Young Adults with Sickle Cell Disease |
Robert Liem, MD |
| 23 |
The Clinical Pharmacology of Hydroxyurea in Pediatric Patient's with Sickle Cell Disease |
Robert Liem, MD |
| |
|
|
| |
Thalassemia |
Investigator |
| 24 |
Novartis US04 - Evaluating Cardiac T2 Star in Beta Thalassemia Patients on ICL |
Alexis Thompson, MD |
| 25 |
Rand. Trial Comparing DFO and L1 Effects on Cardiac Func in B Thal Adult Pts |
Alexis Thompson, MD |
| 26 |
Thalassemia Data Collection (CDC) |
Alexis Thompson, MD |
| 27 |
Thalassemia Longitudinal Cohort (TLC) |
Alexis Thompson, MD |